Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Alterations in Spiking Following Muscle Fatigue in Volleyball Players

1. juli 2026 opdateret af: National Yang Ming Chiao Tung University

Alterations in Spiking Kinematic, Muscle Activation, and Subacromial Structures Following Muscle Fatigue in Volleyball Players

This study aims (1)to investigate the effects of repetitive functional overhead movements targeting shoulder and scapular muscles on glenohumeral and scapular kinematics and muscle activation during the arm cocking and acceleration of spiking, and changes in subacromial structures in healthy recreational volleyball players; (2) to compare these fatigue-related changes between athletes with good and poor shoulder motor control.

Studieoversigt

Status

Ikke rekrutterer endnu

Betingelser

Undersøgelsestype

Observationel

Tilmelding (Anslået)

35

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiekontakt

Studiesteder

      • Taipei, Taiwan, 112
        • National Yang Ming Chiao Tung University
        • Kontakt:
          • National Yang Ming Chiao Tung University
          • Telefonnummer: (02)2826-7049
          • E-mail: tshuang@nycu.edu.tw

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

  • Voksen

Tager imod sunde frivillige

Ja

Prøveudtagningsmetode

Sandsynlighedsprøve

Studiebefolkning

Healthy recreational volleyball players

Beskrivelse

Inclusion Criteria:

  • Between 18 and 35 years old
  • At least 2 consecutive years of volleyball experience
  • Involved in volleyball practice or game for at least 4 hours per week
  • Able to perform a cross-body spike with 3-step

Exclusion Criteria:

  • A history of major shoulder or spinal injury or surgery
  • Experiencing shoulder pain (VAS ≥ 3/10) in the last 6 months

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

Kohorter og interventioner

Gruppe / kohorte
Intervention / Behandling
Poor shoulder motor control
During shoulder medial rotation up to 60° in supine position, the scapula forward tilts or elevation occurs, difficulties in breathing, performing difficulties, unable to perform 60° medial rotation, glenohumeral anterior translation, fatigue, the need of external feedback and external support.

The subject performed upper extremity D2 diagonal exercise with Thera-band at kneeling position to simulate the arm movement of a volleyball spike. The movement is paced by a metronome at one beat per second, with one movement per beat. If participants could not keep up or become too fatigued, they are allowed to rest for 15 seconds before continuing.

The subject was defined as fatigued, and the fatigue activity was stopped, only when all three of the following cumulative conditions were met:

  1. Until the number of repetitions in that set was less than 50% of the repetitions performed in the first set.
  2. Using the Rating of Perceived Exertion (RPE) on a 6-20 scale, until the subject's RPE was greater than or equal to 15.
  3. If this maximum strength showed a decrease of 25% or more compared to the maximum strength measured before the fatigue activity.
Good shoulder motor control
During shoulder medial rotation up to 60° in supine position, no scapula and glenohumeral compensation, easy to breathing and perform 60° medial rotation without external feedback and external support.

The subject performed upper extremity D2 diagonal exercise with Thera-band at kneeling position to simulate the arm movement of a volleyball spike. The movement is paced by a metronome at one beat per second, with one movement per beat. If participants could not keep up or become too fatigued, they are allowed to rest for 15 seconds before continuing.

The subject was defined as fatigued, and the fatigue activity was stopped, only when all three of the following cumulative conditions were met:

  1. Until the number of repetitions in that set was less than 50% of the repetitions performed in the first set.
  2. Using the Rating of Perceived Exertion (RPE) on a 6-20 scale, until the subject's RPE was greater than or equal to 15.
  3. If this maximum strength showed a decrease of 25% or more compared to the maximum strength measured before the fatigue activity.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Degree of the glenohumeral and scapulothoracic joint during spiking
Tidsramme: Baseline, immediately post-intervention (Day 1)

The kinematics is assessed using an electromagnetic motion tracking system (VIPERTM, Polhemus, USA) to measure the glenohumeral elevation, horizontal abduction/adduction, internal/external rotation, and scapulothoracic retraction/protraction, upward/downward rotation, anterior/posterior tilt during spiking movement. During the test, participants performed 3 times of cross-body spikes, with 15 seconds of rest between each trial.

Data were collected at the end of the arm cocking (maximal shoulder horizontal abduction) and at ball-contact (maximal footswitch signal), and reported as mean values for each trial. (unit of measure: degree, °)

Baseline, immediately post-intervention (Day 1)
Activation amplitude of the glenohumeral and periscapular muscles
Tidsramme: Baseline, immediately post-intervention (Day 1)

The muscle activation amplitude of the serratus anterior, upper trapezius, lower trapezius, middle deltoid, infraspinatus, and pectoralis major during spiking movement. During the test, participants performed 3 times of cross-body spikes, with 15 seconds of rest between each trial.

Data were collected in the arm cocking phase (from minimal shoulder elevation to the shoulder maximal horizontal abduction) and the acceleration phase (from maximal shoulder horizontal abduction to the ball-contact), and reported as mean values for each trial. (unit of measure: percentage, %)

Baseline, immediately post-intervention (Day 1)
Mean power frequency of the glenohumeral and periscapular muscles
Tidsramme: Baseline, immediately post-intervention (Day 1)

The mean power frequency of the serratus anterior, upper trapezius, lower trapezius, middle deltoid, infraspinatus, and pectoralis major during spiking movement. During the test, participants performed 3 times of cross-body spikes, with 15 seconds of rest between each trial.

Data were collected in the arm cocking phase (from minimal shoulder elevation to the shoulder maximal horizontal abduction) and the acceleration phase (from maximal shoulder horizontal abduction to the ball-contact), and reported as mean values for each trial. (unit of measure: hertz, Hz)

Baseline, immediately post-intervention (Day 1)

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Acromio-humeral distance and thickness of supraspinatus tendon thickness during arm elevation
Tidsramme: Baseline, immediately post-intervention (Day 1)

The subacromial structures is assessed using a diagnostic ultrasound system (SONIMAGE MX1 Ver. 1.10, Konica Minolta, Inc., Tokyo, Japan) to measure the acromio-humeral distance (AHD, from the lateral inferior edge of the acromion perpendicular to the humerus), supraspinatus tendon thickness (SST, from the subacromial-subdeltoid bursa perpendicular to the humerus), occupation ratio (OR, dividing SST by AHD). During the dynamic evaluation, participants performed 3 times of arm elevation to 90° and returning to the neutral position at scapular plane. During the static evaluation, participants performed 3 times of arm elevation to 60° at scapular plane.

Data of dynamic evaluation is collected at 0° elevation and at the greater tuberosity of the humerus is aligned under the lateral inferior edge of the acromion. Data of static evaluation is collected at 0° elevation and 60° elevation. Data reported as mean values for each trial. (unit of measure: millimeter, mm)

Baseline, immediately post-intervention (Day 1)
Degree of shoulder elevation at greater tuberosity-acromion alignment during arm elevation
Tidsramme: Baseline, immediately post-intervention (Day 1)
The shoulder elevation angle is measured using a application software (Measure, Apple Inc., USA) at at greater tuberosity of humerus under Lateral inferior edge of the acromion, which assess diagnostic ultrasound system (SONIMAGE MX1 Ver. 1.10, Konica Minolta, Inc., Tokyo, Japan), and reported as mean values for each trial. (unit of measure: degree, °).
Baseline, immediately post-intervention (Day 1)

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Anslået)

1. juli 2026

Primær færdiggørelse (Anslået)

1. januar 2027

Studieafslutning (Anslået)

1. januar 2027

Datoer for studieregistrering

Først indsendt

17. december 2025

Først indsendt, der opfyldte QC-kriterier

1. juli 2026

Først opslået (Faktiske)

7. juli 2026

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

7. juli 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

1. juli 2026

Sidst verificeret

1. november 2025

Mere information

Begreber relateret til denne undersøgelse

Andre undersøgelses-id-numre

  • NYCU114118AF

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

3
Abonner